Sign in
Taking peopleNo phase

Deep Brain Stimulation to Understand and Treat Addiction

Key facts

Who runs it
University of Cambridge
Where
United Kingdom2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
9 people, planned
Started
1 Jul 2025
Expected to end
31 Oct 2027
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Dual-Target Deep Brain Stimulation
  • Nucleus Accumbens Deep Brain Stimulation
  • Ventral Internal Capsule Deep Brain Stimulation
  • Sham Deep Brain Stimulation
Record updated
24 March 2026

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 34 criteriaShow less

Who can take part

  • Adults aged 18 to 60 years
  • Diagnosed with Alcohol Use Disorder (AUD) according to DSM-5 criteria
  • Primary diagnosis of treatment-refractory AUD (comorbid nicotine dependence, other psychoactive substance use disorders, moderate major depressive disorder, anxiety disorders or obsessive-compulsive disorder are permissible if AUD is principal)
  • Disorder duration of AUD ≥ 5 years
  • At least 3 unsuccessful attempts at achieving abstinence
  • Failed prior psychotherapy and standard pharmacotherapy for AUD
  • Medically and neurologically suitable for surgery and MRI-compatible
  • Capable of providing informed consent and willing to comply with study procedures

Who cannot take part

  • Previous treatment with electroconvulsive therapy (ECT)
  • Significant neurological history, including prior hemorrhagic or ischemic stroke, subarachnoid hemorrhage, or other major neurological illness
  • Current or previous anticoagulant use
  • Inadequate logistical or social support that would impair the safe conduct of deep brain stimulation therapy, including inability to reliably attend scheduled visits, lack of reasonable access to the study site, or inadequate home or caregiver support necessary for postoperative care, device management and follow-up
  • Severe psychiatric disorder other than Alcohol Use Disorder (e.g., schizophrenia, schizoaffective disorder, bipolar disorder)
  • Severe major depressive disorder (moderate depression acceptable)
  • Current active suicidal ideation or history of serious suicide attempts
  • Cardiac pacemaker or defibrillator (or clinical indication for pacemaker placement)
  • Any significant medical condition that, in the opinion of the clinical team, would increase surgical or anesthetic risk
  • Increased risk of bleeding (as determined by hepatology/hematology review)
  • History of coagulopathy
  • Uncontrolled hypertension (controlled hypertension with medication is acceptable)
  • History of major cardiac arrhythmia (e.g., atrial fibrillation) or need for anti-arrhythmic medication
  • History of requiring cardioversion
  • History of repeated falls
  • History of major head injury
  • Marked cognitive impairment
  • Seizure history, including multiple alcohol withdrawal seizures
  • Presence of implanted electrical devices, including:
  • Implanted vagus nerve stimulator (VNS)
  • Any other chronically implanted neurostimulation device
  • Current pregnancy
  • Contraindications to deep brain stimulation or neurosurgery, including:
  • Inability to tolerate general anesthesia (as assessed by anesthesiology)
  • Stage 4 liver cirrhosis
  • Marked cortical atrophy on neuroimaging

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is testing whether deep brain stimulation (DBS) can safely help people with severe alcohol use disorder who have not improved with standard treatments. DBS uses small electrical signals to change activity in brain areas linked to craving, self-control, and emotion. The study will test whether this treatment can reduce how often people drink and how much they drink each day. Researchers will also record brain activity to better understand how DBS affects craving and relapse.

The 4 groups in the trial

  • Dual Stimulation (Nucleus Accumbens + Ventral Internal Capsule)Treatment being tested

    Participants receive active deep brain stimulation simultaneously targeting both the nucleus accumbens and the ventral internal capsule.

    Treatment: Dual-Target Deep Brain Stimulation

  • Single Stimulation - Nucleus Accumbens OnlyExisting treatment, for comparison

    Participants receive active deep brain stimulation targeting the nucleus accumbens only, with ventral internal capsule stimulation inactive.

    Treatment: Nucleus Accumbens Deep Brain Stimulation

  • Single Stimulation - Ventral Internal Capsule OnlyExisting treatment, for comparison

    Participants receive active deep brain stimulation targeting the ventral internal capsule only, with nucleus accumbens stimulation inactive.

    Treatment: Ventral Internal Capsule Deep Brain Stimulation

  • Sham Stimulation (Inactive)Sham treatment, for comparison

    Participants receive sham (inactive) deep brain stimulation. The implanted device is turned off; no therapeutic stimulation is provided.

    Treatment: Sham Deep Brain Stimulation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Deep Brain Stimulation for Disorders of Addiction: Mechanisms and a Pilot Blinded Randomized Cross-over Placebo Controlled Trial
Fit questions
Built from NCT07341230, who can take part
Record updated
24 March 2026